Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease (Q46477192)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 October 2016

Language	Label	Description	Also known as
English	Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease	scientific article published on 3 October 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease (English)

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Philadelphia chromosome

1 reference

object named as

Philadelphia chromosome

2 August 2024

based on heuristic

inferred from title

Nicholas J. Short

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/27696391

object named as

Koji Sasaki

8

0 references

Hagop Kantarjian

2

object named as

Hagop M Kantarjian

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

Gautam Borthakur

13

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

5

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

21

object named as

Elias Jabbour

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

19

object named as

Sherry Pierce

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

Guillermo Garcia-Manero

9

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

Jorge Eduardo Cortes

11

object named as

Jorge E Cortes

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

Marina Konopleva

15

object named as

Marina Konopleva

1 reference

Europe PubMed Central

20 February 2018

PMC publication ID

10

object named as

Tapan M Kadia

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

3

object named as

C Cameron Yin

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

12

object named as

Naval Daver

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

1

object named as

Ghayas C Issa

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Richard E Champlin

18

object named as

Richard E Champlin

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Partow Kebriaei

17

object named as

Partow Kebriaei

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

16

object named as

Issa Khouri

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Susan M O'Brien

20

object named as

Susan M O'Brien

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

author name string

Wei Qiao

4

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Deborah Thomas

6

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Nitin Jain

14

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

language of work or name

0 references

publication date

3 October 2016

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

123

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

3

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

459-467

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Detection and management of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

The genomic landscape of hypodiploid acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

24 May 2018

Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

15 August 2018

Genetic variegation of clonal architecture and propagating cells in leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

15 August 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5321542

15 August 2018

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30376

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30376

7 January 2021

based on heuristic

inferred from DOI database lookup

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30376

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30376

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27696391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27696391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.30376

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 February 2018

http://europepmc.org/abstract/PMC/5321542

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46477192&oldid=2218892810"